BAJAJ BROKING

Notification close image
No new Notification messages
card image
Smartworks Coworking Spaces IPO is Open!
Apply for the Smartworks Coworking Spaces IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

12384

541400

ZIMLAB

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ZIM LABORATORIES LIMITED performance

Today’s low

Today’s high

₹ 114.80 ₹ 116.38
₹ 114.93

52 week low

52 week high

₹ 79.49 ₹ 128.90
₹ 114.93

Open Price

₹ 116.00

Prev. Close

₹ 116.00

Volume (Shares)

66305.00

Total traded value

₹ 76.20

Upper Circuit

₹ 139.20

Lower Circuit

₹ 92.80

info

ZIM LABORATORIES LIMITED Share Price Update

As of the latest trading session, ZIM LABORATORIES LIMITED share price is currently at ₹ 115.37, which is down by ₹ -0.62 from its previous closing. Today, the stock has fluctuated between ₹ 114.80 and ₹ 116.38. Over the past year, ZIM LABORATORIES LIMITED has achieved a return of 5.90 %. In the last month alone, the return has been 13.79 %. Read More...

Investment Returns

Over 1 Month 13.79% Over 3 Months 34.91% Over 6 Months 12.25% Over 1 Year 5.90%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ZIM LABORATORIES LIMITED fundamentals


  • Market cap (Cr)

    560.00

  • P/E Ratio (TTM)

    48.13

  • Beta

    0.87

  • Book Value / share

    49.90

  • Return on equity

    4.93%

  • EPS (TTM)

    2.41

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    5.42

info icon alternate text
  • Market cap (Cr)

    560.10

  • P/E Ratio (TTM)

    48.13

  • Beta

    0.74

  • Book Value / share

    49.90

  • Return on equity

    4.93%

  • EPS (TTM)

    2.41

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    5.42

info icon alternate text

ZIM LABORATORIES LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 108.52
Operating Expense 101.42
Net Profit 5.42
Net Profit Margin (%) 4.99
Earnings Per Share (EPS) 1.11
EBITDA 16.79
Effective Tax Rate (%) 37.34
Particulars DEC 2024 (Values in Cr)
Revenue 95.40
Operating Expense 91.13
Net Profit 4.35
Net Profit Margin (%) 4.55
Earnings Per Share (EPS) 0.89
EBITDA 13.53
Effective Tax Rate (%) 27.86
Particulars SEP 2024 (Values in Cr)
Revenue 89.72
Operating Expense 89.20
Net Profit 1.22
Net Profit Margin (%) 1.35
Earnings Per Share (EPS) 0.25
EBITDA 9.71
Effective Tax Rate (%) 34.59
Particulars JUN 2024 (Values in Cr)
Revenue 82.00
Operating Expense 81.90
Net Profit 0.76
Net Profit Margin (%) 0.92
Earnings Per Share (EPS) 0.16
EBITDA 8.86
Effective Tax Rate (%) 30.55
Particulars MAR 2024 (Values in Cr)
Revenue 117.39
Operating Expense 108.12
Net Profit 7.89
Net Profit Margin (%) 6.72
Earnings Per Share (EPS) 1.62
EBITDA 16.95
Effective Tax Rate (%) 26.94
Particulars MAR 2025 (Values in Cr)
Revenue 375.64
Operating Expense 363.65
Net Profit 11.74
Net Profit Margin (%) 3.12
Earnings Per Share (EPS) 2.41
EBITDA 48.89
Effective Tax Rate (%) 33.33
Particulars MAR 2024 (Values in Cr)
Revenue 365.47
Operating Expense 347.12
Net Profit 16.76
Net Profit Margin (%) 4.58
Earnings Per Share (EPS) 3.44
EBITDA 44.79
Effective Tax Rate (%) 27.25
Particulars MAR 2023 (Values in Cr)
Revenue 396.53
Operating Expense 367.05
Net Profit 25.01
Net Profit Margin (%) 6.30
Earnings Per Share (EPS) 5.13
EBITDA 57.62
Effective Tax Rate (%) 30.37
Particulars MAR 2022 (Values in Cr)
Revenue 329.49
Operating Expense 314.71
Net Profit 13.01
Net Profit Margin (%) 3.94
Earnings Per Share (EPS) 8.01
EBITDA 42.45
Effective Tax Rate (%) 32.53
Particulars MAR 2021 (Values in Cr)
Revenue 303.63
Operating Expense 292.32
Net Profit 5.62
Net Profit Margin (%) 1.85
Earnings Per Share (EPS) 3.46
EBITDA 34.08
Effective Tax Rate (%) 34.49
Particulars MAR 2025 (Values in Cr)
Book Value / Share 51.49
ROE % 4.96
ROCE % 8.16
Total Debt to Total Equity 0.47
EBITDA Margin 13.06
Particulars MAR 2024 (Values in Cr)
Book Value / Share 49.00
ROE % 7.86
ROCE % 9.97
Total Debt to Total Equity 0.40
EBITDA Margin 12.66
Particulars MAR 2023 (Values in Cr)
Book Value / Share 41.12
ROE % 12.99
ROCE % 16.65
Total Debt to Total Equity 0.31
EBITDA Margin 14.65
Particulars MAR 2022 (Values in Cr)
Book Value / Share 108.18
ROE % 8.65
ROCE % 12.43
Total Debt to Total Equity 0.40
EBITDA Margin 13.61
Particulars MAR 2021 (Values in Cr)
Book Value / Share 98.97
ROE % 7.01
ROCE % 10.80
Total Debt to Total Equity 0.55
EBITDA Margin 13.70
Particulars MAR 2025 (Values in Cr)
Book Value / Share 49.90
ROE % 4.93
ROCE % 8.21
Total Debt to Total Equity 0.48
EBITDA Margin 13.02
Particulars MAR 2024 (Values in Cr)
Book Value / Share 47.60
ROE % 7.87
ROCE % 9.99
Total Debt to Total Equity 0.41
EBITDA Margin 12.26
Particulars MAR 2023 (Values in Cr)
Book Value / Share 39.85
ROE % 13.73
ROCE % 17.30
Total Debt to Total Equity 0.32
EBITDA Margin 14.53
Particulars MAR 2022 (Values in Cr)
Book Value / Share 104.73
ROE % 7.95
ROCE % 11.92
Total Debt to Total Equity 0.41
EBITDA Margin 12.88
Particulars MAR 2021 (Values in Cr)
Book Value / Share 96.69
ROE % 5.84
ROCE % 10.24
Total Debt to Total Equity 0.56
EBITDA Margin 12.93
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.49
Total Assets 472.02
Total Liabilities 472.02
Total Equity 252.23
Share Outstanding 48725814
Price to Book Ratio 1.61
Return on Assets (%) 2.57
Return on Capital (%) 3.34
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 10.46
Total Assets 446.82
Total Liabilities 446.82
Total Equity 238.74
Share Outstanding 48725814
Price to Book Ratio 2.01
Return on Assets (%) 3.85
Return on Capital (%) 5
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.51
Total Assets 341.57
Total Liabilities 341.57
Total Equity 200.34
Share Outstanding 48725814
Price to Book Ratio 1.82
Return on Assets (%) 7.15
Return on Capital (%) 9.4
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.97
Total Assets 341.62
Total Liabilities 341.62
Total Equity 175.70
Share Outstanding 16241938
Price to Book Ratio 1.53
Return on Assets (%) 4.25
Return on Capital (%) 6.41
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 8.35
Total Assets 324.78
Total Liabilities 324.78
Total Equity 160.75
Share Outstanding 16241938
Price to Book Ratio 0.75
Return on Assets (%) 2.25
Return on Capital (%) 3.03
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.81
Total Assets 464.38
Total Liabilities 464.38
Total Equity 244.51
Share Outstanding 48725814
Price to Book Ratio 1.61
Return on Assets (%) 2.52
Return on Capital (%) 3.29
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.75
Total Assets 442.50
Total Liabilities 442.50
Total Equity 231.95
Share Outstanding 48725814
Price to Book Ratio 2.01
Return on Assets (%) 3.78
Return on Capital (%) 4.95
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.20
Total Assets 334.86
Total Liabilities 334.86
Total Equity 194.17
Share Outstanding 48725814
Price to Book Ratio 1.82
Return on Assets (%) 7.46
Return on Capital (%) 9.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.09
Total Assets 335.42
Total Liabilities 335.42
Total Equity 170.10
Share Outstanding 16241938
Price to Book Ratio 1.53
Return on Assets (%) 3.87
Return on Capital (%) 5.88
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 7.86
Total Assets 320.27
Total Liabilities 320.27
Total Equity 157.04
Share Outstanding 16241938
Price to Book Ratio 0.75
Return on Assets (%) 1.75
Return on Capital (%) 2.36
Particulars MAR 2025 (Values in Cr)
Net Income 18.00
Cash from Operations 40.07
Cash from Investing -39.92
Cash from Financing -9.10
Net change in Cash -7.65
Free Cash Flow 80.87
Particulars MAR 2024 (Values in Cr)
Net Income 23.64
Cash from Operations 18.86
Cash from Investing -73.01
Cash from Financing 59.53
Net change in Cash 3.17
Free Cash Flow 92.78
Particulars MAR 2023 (Values in Cr)
Net Income 35.35
Cash from Operations 45.31
Cash from Investing -36.20
Cash from Financing 0.54
Net change in Cash 3.00
Free Cash Flow 81.98
Particulars MAR 2022 (Values in Cr)
Net Income 21.04
Cash from Operations 49.63
Cash from Investing -14.57
Cash from Financing -32.97
Net change in Cash 2.02
Free Cash Flow 64.86
Particulars MAR 2021 (Values in Cr)
Net Income 15.41
Cash from Operations 32.96
Cash from Investing -5.88
Cash from Financing -25.97
Net change in Cash -0.06
Free Cash Flow 39.44
Particulars MAR 2025 (Values in Cr)
Net Income 17.61
Cash from Operations 49.31
Cash from Investing -41.31
Cash from Financing -9.10
Net change in Cash 0.19
Free Cash Flow 87.23
Particulars MAR 2024 (Values in Cr)
Net Income 23.03
Cash from Operations 14.04
Cash from Investing -71.94
Cash from Financing 59.53
Net change in Cash -0.93
Free Cash Flow 86.63
Particulars MAR 2023 (Values in Cr)
Net Income 35.91
Cash from Operations 42.21
Cash from Investing -35.20
Cash from Financing 0.54
Net change in Cash 0.56
Free Cash Flow 77.88
Particulars MAR 2022 (Values in Cr)
Net Income 19.29
Cash from Operations 47.25
Cash from Investing -14.41
Cash from Financing -32.97
Net change in Cash -0.36
Free Cash Flow 62.22
Particulars MAR 2021 (Values in Cr)
Net Income 13.76
Cash from Operations 32.95
Cash from Investing -5.70
Cash from Financing -25.96
Net change in Cash 0.23
Free Cash Flow 39.25
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.19 32.03 1.98 277.34 34.11 / 77.70
BLISS GVS PHARMA LTD 155.40 19.45 1.56 1638.62 105.05 / 184.95
CIPLA LTD 1491.80 23.42 3.86 120493.85 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 356.25 13.64 2.88 1048.48 189.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.19 92.79 5.71 277.34 34.11 / 77.70
AMRUTAJAN HEALTH LTD 717.40 40.81 6.35 2074.05 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 9296.00 132.76 30.16 23240.00 6222.35 / 10653.05
BLISS GVS PHARMA LTD 155.40 23.76 1.54 1638.62 105.05 / 184.95

ZIM LABORATORIES LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
114.93 -0.92 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 113.10
  • 26 Days 107.20
  • 10 Days 111.70
  • 50 Days 102.20
  • 12 Days 111.20
  • 100 Days 99.20
  • 20 Days 108.90
  • 200 Days 100.60
115.55 PIVOT

First Support

113.95

First Resistance

117.59

Second Support

111.91

Second Resistance

119.19

Third Support

110.31

Third Resistance

121.23

RSI

69.59

ADX

53.96

MACD

3.95

Williams % R

-13.38

Commodity Channel Index (CCI)

139.94

Date

2025-07-09

Week

53214.00

Same Day

96598.00

Month

51649.00

1 Year

0.87

3 Year

0.90

Over 1 Month

13.79%

down

Over 1 Year

5.90%

down

Over 3 Months

34.91%

down

Over 3 Years

1.13%

down

Over 6 Months

12.25%

down

Over 5 Years

0.00%

down

ZIM LABORATORIES LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
66.48%
Promoter Holdings
33.26%
FII
0.01%
DII
0.23%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Anwar Daud 1.333632E7 (27.37%) Shareholding of Promoter and Promoter Group
Elizabeth Mathew 5855824.0 (12.02%) Public Shareholding
Zakir S Vali 5047420.0 (10.36%) Public Shareholding
Sabbah Zulfiquar Kamal 1500000.0 (3.08%) Shareholding of Promoter and Promoter Group
Bonanza Business Services Pvt Ltd 1240000.0 (2.54%) Public Shareholding
Zulfiquar Murtuza Kamal 1195260.0 (2.45%) Shareholding of Promoter and Promoter Group
Dr Iguer Abdelmounaim 1165680.0 (2.39%) Public Shareholding
Dhoot Industrial Finance Ltd 700659.0 (1.44%) Public Shareholding
Jyoti Bharat Sheth 670943.0 (1.38%) Public Shareholding
Laadki Trading And Investments Limited 669120.0 (1.37%) Public Shareholding
Hasan Kamal 104400.0 (0.21%) Shareholding of Promoter and Promoter Group
Shabbar Daud 42000.0 (0.09%) Shareholding of Promoter and Promoter Group
Tasneem Anwar Daud 30000.0 (0.06%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

ZIM LABORATORIES LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2019 0.5 Final 23 Sep 2019 Equity shares
03 Sep 2018 1.0 Final 04 Sep 2018 Equity shares
Ex-Date Ex-Bonus Ratio
22 Dec 2022 22 Dec 2022 2:1
06 Oct 2018 04 Oct 2018 1:1
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2019 0.5 Final 23 Sep 2019 Equity shares
03 Sep 2018 1.0 Final 04 Sep 2018 Equity shares
Ex-Date Ex-Bonus Ratio
22 Dec 2022 22 Dec 2022 2:1
06 Oct 2018 04 Oct 2018 1:1
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

ZIM LABORATORIES LIMITED Share Price

Zim Laboratories Ltd was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in the State of Maharashtra. The Company became a Public Limited Company through fresh Certificate of Incorporation issued by the Registrar of Companies, Maharashtra, Mumbai. The Company is engaged in the manufacturing of formulation on drugs and pre formulation ingredients in India and marketing and selling these within and outside India. The Pharma Industry is dominated by Multinationals, Large Indian companies and in the lower end of the market large number of units mainly in the SSI sector.

During the year 2019-20, ZIM Health Technologies Limited was acquired thereby resulting as a wholly owned subsidiary of the company . SIA ZIM Laboratories Limited got incorporated as a wholly owned subsidiary in Latvia.

In 2023, the Company launched Thinoral (Patented Oral Thin Film technology) as an alternate drug delivery platform across RoW/
Pharmerging Markets and EU.

Parent organization Indian Private
NSE symbol ZIMLAB
Founded 1984
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Zim Laboratories Ltd?

Answer Field

Zim Laboratories Ltd share price is for NSE ₹ 115.37 & for BSE ₹ 115.40 as on Jul 10 2025 03:29 PM.

What is the Market Cap of Zim Laboratories Ltd Share?

Answer Field

The market cap of Zim Laboratories Ltd for NSE ₹ 562.14 & for BSE ₹ 562.29 as on Jul 10 2025 03:29 PM.

What is the 52 Week High and Low of Zim Laboratories Ltd?

Answer Field

The 52 Week High and Low of Zim Laboratories Ltd for NSE is ₹ 128.90 and ₹ 79.49 and for BSE is ₹ 128.45 and ₹ 79.50.

What is 1 year return for Zim Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 5.90%.

What is the P/E Ratio of Zim Laboratories Ltd Share?

Answer Field

As on Jul 10 2025 03:29 PM the price-to-earnings (PE) ratio for Zim Laboratories Ltd share is 48.13.

What is the PB ratio of Zim Laboratories Ltd Share?

Answer Field

As on Jul 10 2025 03:29 PM, the price-to-book (PB) ratio for Zim Laboratories Ltd share is 49.90.

How to Buy Zim Laboratories Ltd Share?

Answer Field

You can trade in Zim Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Zim Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Zim Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Zim Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|